{
  "id": "00818079310e2f48",
  "title": "STAT+: Trump administration is urged to use a federal law to authorize generic versions of GLP-1 drugs",
  "description": "Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be authorized.",
  "content": "Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be authorized.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/02/12/patents-obesity-novo-lilly-generics-wegovy-zepbound/?utm_campaign=rss",
  "published_at": "2026-02-12T22:00:46+00:00",
  "fetched_at": "2026-02-13T00:31:20.432552+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "training",
    "drug",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Trump administration is urged to use a federal law to authorize generic versions of GLP-1 drugs",
    "description": "Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be authorized.",
    "url": "https://www.statnews.com/pharmalot/2026/02/12/patents-obesity-novo-lilly-generics-wegovy-zepbound/?utm_campaign=rss",
    "published": "2026-02-12T22:00:46+00:00",
    "source": "STAT"
  }
}